Accession | ARO:3007148 |
Definition | An antibiotic cocktail containing the beta-lactam antibiotic cefepime and the beta-lactamase inhibitor taniborbactam. As of 2022, this antibiotic-adjuvant mixture is in phase III clinical trials for the treatment of various bacterial infections. |
SMILES | N/A |
Drug Class | cephalosporin |
Classification | 12 ontology terms | Show + process or component of antibiotic biology or chemistry + resistance-modifying agents + inhibitor of antibiotic resistance mechanism + antibiotic molecule + beta-lactamase inhibitor + beta-lactam antibiotic + metallo-beta-lactamase inhibitor + serine beta-lactamase inhibitor + cephalosporin [Drug Class] + fourth-generation cephalosporin + unclassified metallo-beta-lactamase inhibitor + boronic acid beta-lactamase inhibitor |
Parent Term(s) | 3 ontology terms | Show |
Sub-Term(s) | 1 ontology terms | Show + NDM-9 confers_resistance_to_antibiotic |
Publications | Hamrick JC, et al. 2020. Antimicrob Agents Chemother 64(3): VNRX-5133 (Taniborbactam), a Broad-Spectrum Inhibitor of Serine- and Metallo-β-Lactamases, Restores Activity of Cefepime in Enterobacterales and Pseudomonas aeruginosa. (PMID 31871094) |
Curator | Description | Most Recent Edit |
---|